Investment
Features
FeesSafety
Academy
More
Pluang+

Cream cheese and deli salads recalled over listeria risk in NYC; no illnesses reported yet.

Market News
10 Sep 2026
Fox Business
View Source
Bearish
Cream cheese and deli salads recalled over listeria risk in NYC; no illnesses reported yet.

Made Fresh Salads, Inc. has recalled all its cream cheese products and ready-to-eat deli-style salads due to potential listeria contamination. The recall affects various cream cheese flavors and multiple salad types distributed in Brooklyn, Queens, and the Bronx, with expiration dates from Sept. 3 to Sept. 18. The recall follows positive listeria findings in the company's facility during FDA and company testing. Production and distribution have stopped while investigations continue. No illnesses have been reported, but consumers are advised to return affected products for a refund due to the serious health risks listeria poses, especially to vulnerable groups.

More News

AIG's price target adjusted to $80 as Q3 earnings approach, showing strong underwriting gains and AI integration.

AIG's price target adjusted to $80 as Q3 earnings approach, showing strong underwriting gains and AI integration.

Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...

Analyst Insights
Bullish
2 hours ago
Vertiv Holdings sees mixed analyst ratings amid strong cash flow and data center product growth.

Vertiv Holdings sees mixed analyst ratings amid strong cash flow and data center product growth.

Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...

Analyst Insights
Neutral
2 hours ago
Apogee Enterprises beats Q2 earnings and revenue estimates, raises optimistic fiscal 2027 outlook.

Apogee Enterprises beats Q2 earnings and revenue estimates, raises optimistic fiscal 2027 outlook.

Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...

Company Fundamentals
Bullish
2 hours ago
McKesson targets $977 and acquires Option Care Health for $5.8B to expand home infusion services.

McKesson targets $977 and acquires Option Care Health for $5.8B to expand home infusion services.

McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...

Market News
Bullish
3 hours ago
Ameriprise Financial boosts share buybacks with $5.5B authorization, seen as value play by investors.

Ameriprise Financial boosts share buybacks with $5.5B authorization, seen as value play by investors.

Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App